Sites Are Not Created Equal

Case Studies

Problem:

Why try to push a square peg into a round hole? It’s an old saw, but a true one: investigator Sites in clinical trials are widely different in their procedures, their facilities, their local challenges, their staff, their suppliers, their idiosyncrasies. How then does a Project Manager (PM) standardize important aspects of the trial — things like shipping and resupply processes, predictive algorithms, drug sourcing, and more?

Managing Supplemental Supplies with your IRT

Newsletter Archive

Required Non-Investigational Materials

It doesn’t seem like a big deal until you have to do it – managing the bandages, syringes, saline solution, tubing, and so on, that Sites may require during the conduct of your clinical trial. The non-investigational materials required for use at clinic visits are often regarded as ‘no-brainers’, not demanding much forethought or attention. But it takes only one or two experiences in a complex trial for Clinical Project Managers (PMs) to concede that developing and managing processes for ordering, reordering, controlling limits on the amount ordered, and managing the users authorized to order supplemental materials is an important part of the efficient – and painless– execution of a clinical study.

Protecting the Study Blind in IRT Processing

Case Studies, IRT Essentials

In recent years there has been an upsurge in professional vigilance with regard to maintaining the study blind in clinical trials. Concern about incidental unblinding — i.e., an unblinding or ‘partial unblinding’ that occurs accidentally in the course of modifying some other aspect of a trial– has grown in proportion to new strategies and techniques adopted by the industry. These concerns apply to all sectors of a study strategy, including outsourced players like IRT (IWR/IVR) systems. Veracity Logic founder Steve Zimmerman led a panel of colleagues in discussion of this subject at the CBI IRT conference in Philadelphia in 2015.